Medspas are leading the charge in offering GLP-1 treatments, with 60% of medspas in the U.S. now providing these services, compared to 35% of aesthetic physician offices. Average spend per patient ...
Diet food brands have been hit in recent years, but now GLP-1 drugs like Ozempic are hitting the market, will this spell the ...
With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.
The GLP-1s include semaglutide (Ozempic, Wegovy) and the combination of GLP-1/GIP drug tirzepatide (Mounjaro, Zepbound).
Digital technologies loom large on the list—from the growing impact of artificial intelligence to the need for tech-enabled ...
As GLP-1 RA use soars, experts are worried that patients may not be getting the right nutrients in their diets. How can ...
As usage of the medications increases, Circana research indicates deli and produce could be bright spots for spending.
Novo Nordisk (NVO) and Eli Lilly's (LLY) weight loss drugs lead Evaluate Pharma’s list of best-selling drugs projected for ...
Holiday weight gain hits home for many come January. These days, folks making resolutions to slim down and get fit have an ...
The FDA has approved Liraglutide Injection, the first generic version of Victoza, for the treatment of type 2 diabetes.
Industry leaders share their thoughts and concerns about the health care landscape and how it will affect their 2025.
Eli Lilly and Company’s LLY shares declined 13.5% in the past three months. Though demand for its popular tirzepatide drugs, ...